Wenn schon die Auditoren Bedenken haben, sollte man zumindest genauer hinschauen:
Emphasis of Matter
Without qualifying our opinion, we draw attention to Note 1 in the consolidated financial statements which describes conditions and matters that indicate the existence of a material uncertainty that may cast significant doubt about True Leaf
Medicine International Ltd.’s ability to continue as a going concern.
“DAVIDSON & COMPANY LLP” Vancouver, Canada Chartered Professional Accountants
July 27, 2015
Note 1: "...For the year ended March 31, 2015, the Company incurred a loss of $2,166,805 and has not earned any revenues since inception. The continued operations of the Company are dependent on its ability to generate future cash flows or obtain additional funding through private placement financings.
Management is of the opinion that it does not have sufficient working capital to fund future operations and will require external financing. There is a risk that financing will not be available on a timely basis or on terms acceptable to the Company. These material uncertainties may cast significant doubt on the
Company’s ability to continue as a going concern..."
Quelle: Audited annual financial statements vom 28.7.2015; sedar.com
|
